The 2025 YouGov survey data from more than 31,000 US adults show significant support for recreational cannabis legalization, medical use, and federal reclassification.
News|Articles|February 8, 2024
Studies on Cannabis for Anxiety and PTSD: A New Webinar from Healer
Author(s)Erin McEvoy
The latest Healer webinar provided a research update and analysis on recent studies that treated anxiety and PTSD symptoms with cannabis.
Advertisement
This two-hour webinar, hosted by Dustin Sulak, DO, co-founder of Healer, on February 7th, 2024, gave an in-depth analysis of several studies published within the last six months that used cannabis to treat symptoms of anxiety or post-traumatic stress disorder (PTSD). Healer webinars, Dr. Sulak explained, were started in 2018 to help filter through the large number of cannabis studies being published. The recent increase in studies on cannabis for anxiety and PTSD, plus Dr. Sulak’s own experience treating patients with these conditions, prompted the focus of well-received webinar.
The first studies Dr. Sulak reviewed were on cannabis for treating anxiety. For each of the studies presented, he discussed the setup, effects of the type of cannabis or the cannabinoids used, results, and limitations, focusing in particular on duration of symptom relief, drug substitution for the first-time cannabis users, and major takeaways from each study.
Dr. Sulak then explained how he viewed some overlap between the roots of anxiety and PTSD. The two studies on cannabis and PTSD presented in the webinar were small and hard to draw huge conclusions from, Dr. Sulak explained, though the statistically significant results highlighted a need for more research in this area. In addition to the details of the studies’ set ups and limitations, he discussed the effect of use frequency on symptoms and notable baseline comparisons.
Also addressed in the webinar was the mechanism of action for cannabigerol (CBG) when used for treating anxiety, including dosing and cautions. Dr. Sulak also provided his own treatment recommendations for people with anxiety disorders and PTSD based on results from his own practice.
The end of the webinar was dedicated to addressing questions from attendees. Topics included substituting CBG for CBD, CBG replacing 5HTP, and how to consume medical cannabis safely around children and other sensitive groups.
Find more information on upcoming
Advertisement
Related to this article
Curaleaf is opening a new cannabis dispensary called Curaleaf Millcreek in Erie, Pennsylvania.
Learn how third-party audits enhance compliance in the cannabis industry, ensuring readiness for evolving regulations and fostering consumer trust.
Let’s take a look at the 2025 cannabis coverage on medical cannabis research and medicine to catch up on industry trends and innovations.
Let’s take a look at the 2025 cannabis coverage on cannabis research to catch up on industry trends and innovations.
A lack of standards for cannabis vape devices puts consumers at risk, but several organizations are committed to the research, collaboration, and solutions needed to promote safety and quality in the industry.
Cannabis genetics fundamentally dictate the plant's potential for chemical signatures, including cannabinoid and terpene profiles, and physical traits, such as yield. Cultivators use selective techniques, such as "stacking," to enhance specific compounds. Ultimately, successful cultivation involves balancing superior genetics with environmental "levers" to optimize gene expression and create targeted strains.
It’s that time of year again—the Cannabis Science and Technology (CST) top 10 articles from the previous year. CST published a wide variety of content throughout 2025. Here is just a small snippet of some of the top articles that our readers enjoyed. See if any of your favorites made the list!
Advertisement
Advertisement